Last reviewed 2026-04-23 · How we verify

Urine samples

Urine samples are analyzed to detect and monitor various substances and conditions.

Urine samples are analyzed to detect and monitor various substances and conditions. Used for Detection of kidney stones, Diagnosis of urinary tract infections, Monitoring of kidney function.

At a glance

Mechanism of action

This involves testing for the presence of specific compounds, such as drugs, toxins, or biomarkers, in a patient's urine. The results can help diagnose or rule out certain conditions, monitor treatment efficacy, or detect potential health risks.

Approved indications

• Detection of kidney stones
• Diagnosis of urinary tract infections
• Monitoring of kidney function

Common side effects

No common side effects on file.

Key clinical trials

• Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer (PHASE1)
• Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer (PHASE1)
• Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma (PHASE2)
• Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma (PHASE2)
• Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC) (NA)
• A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis (PHASE2)
• MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
• Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.